We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Motif Bio Plc | LSE:MTFB | London | Ordinary Share | GB00BVVT4H71 | ORD 0.01P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.50 | 0.40 | 0.55 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/5/2017 11:59 | Sitting with these and KOD at the moment. Based on the facts both are set to soar. Ignore the profit takers and hold tight imho. The big bucks will come to those who are patient. | cudmore | |
08/5/2017 16:00 | cheers DrMaccers That seems a long time away. Anyone know what news is expected next and when? | nick rubens | |
05/5/2017 16:07 | Well maybe we are indeed now at bottom of retrace. | brucie5 | |
05/5/2017 14:17 | Here's a chart to show my thinking. I've displayed both the 150 and 200sma. In the first, we're still in bullish territory, though seeking support around 31/32; in the second, rather less so, and looking for support around 28/29. Personally, I think that would be a bargain. FWIW | brucie5 | |
05/5/2017 14:09 | Yes, disappointing. I had to sell on the way down, to preserve a profit, and thought I'd get back in this morning at just over 33. Difficult to read, but the bullish scenario seems to have temporarily evaporated. Mainly, as with most such situations, a matter of timing. The story still seems extremely good. | brucie5 | |
05/5/2017 13:55 | Well they've not submitted the NDA and won't until after REVIVE 2. Best guess 15 months | drmaccers | |
05/5/2017 13:21 | How long before we know if Iclaprim has got the FDA nod of approval etc? Cheers NR | nick rubens | |
05/5/2017 13:07 | Grabbed someSome poor sods were buying this in 40s | ilovetowin | |
05/5/2017 11:09 | Ready for the next surge up imho | cudmore | |
04/5/2017 22:30 | Surely exercise of warrants will have boosted coffers a bit? | greenroom78 | |
03/5/2017 16:29 | Looks as though it's about to bounce. | banshee | |
03/5/2017 14:39 | They should come out and tell us then if that is the case. Last position was needs more funding to complete Revive 2. Shouldn't be issue at all but planning gone a bit awry maybe due to early release of R1 results? | blueblood | |
03/5/2017 14:28 | Who says the have not?Clearly the are cracking on with REVIVE2, nearly finished in fact. Maybe the CRO is happy to extend a line of credit until the results are in? | drmaccers | |
03/5/2017 12:39 | Funding update required now. Cmon GL you have known about this for 6 months and should have alternative potential financing options identified before Revive 1 results! | blueblood | |
03/5/2017 10:54 | Beginning to drift quite a bit... | rizler | |
03/5/2017 08:54 | Beaufort Securities today retains Speculative Buy and 110p target. | someuwin | |
02/5/2017 11:59 | Profit taking, plus a lot of stale bulls in this one terrified at the prospect of a second botched fund raising I would imagine. Conversely, if they do swing licensing deal(s) for some or all the cash (they presumably don't need the full amount for INSPIRE this year) - the market should be receptive. Alternatively, a placing may already be on the cards, with the usual advance selling hitting the price. | banshee | |
02/5/2017 10:41 | Northland Capital today reiterate BUY MTFB with 90p target. | someuwin | |
01/5/2017 22:52 | 80% of REVIVE 2 enrolled?! Bloody brilliant. | drmaccers | |
27/4/2017 16:56 | Who is this moron?Pump and dump a £70mill stage 3 pharma company?! Lol | drmaccers | |
27/4/2017 15:11 | I see an idiot here........ | qazwsxedc69 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions